Osteoporosis International

, Volume 18, Issue 12, pp 1583–1593 | Cite as

Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications

Original Article

Abstract

Summary

In a cohort of 169,145 patients with a hip fracture and 524,010 controls we observed an excess mortality among patients compared to controls for as long as 20 years after the hip fracture. The main reason for the excess mortality was linked to the trauma that caused the hip fracture.

Introduction

Patients with a hip fracture have a significant excess mortality. However, it remains unclear if the mortality is linked to the pre-morbid conditions or to complications to the fracture.

Methods

All subjects with a hip fracture in Denmark between 1977 and 2001 were compared with three age- and gender-matched subjects from the general population.

Results

A total of 169,145 fracture cases were compared to 524,010 controls. The cases had a much higher prevalence of co-morbidity than the controls. The mortality rate was twice as high in fracture cases compared with controls (HR = 2.26, 95% CI: 2.24–2.27). Adjustments for confounders only changed the excess mortality risk little. The mortality after the hip fracture was divided into two categories: an excess mortality of 19% within the first year following the fracture (relative survival = 0.81 compared to controls), and an excess mortality of 1.8% per year (relative survival 0.982) for every additional year following the fracture. The major causes of the excess mortality were due to complications to the fracture event (70.8% within the first 30 days).

Conclusions

Patients with a hip fracture have a pronounced excess mortality risk. The major cause was linked to the fracture event and not to pre-existing co-morbidity.

Keywords

Cause of death Co-morbidity Hip fracture Mortality 

References

  1. 1.
    Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ (2002) Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc 50:1644–1650PubMedCrossRefGoogle Scholar
  2. 2.
    Jacobsen SJ, Goldberg J, Miles TP et al (1992) Race and sex differences in mortality following fracture of the hip. Am J Public Health 82:1147–1150PubMedGoogle Scholar
  3. 3.
    Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE (1989) Survival experience of aged hip fracture patients. Am J Public Health 79:274–278PubMedCrossRefGoogle Scholar
  4. 4.
    Magaziner J, Lydick E, Hawkes W et al (1997) Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health 87:1630–1636PubMedGoogle Scholar
  5. 5.
    Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15:897–902PubMedCrossRefGoogle Scholar
  6. 6.
    Pitto RP (1994) The mortality and social prognosis of hip fractures. A prospective multifactorial study. Int Orthop 18:109–113PubMedCrossRefGoogle Scholar
  7. 7.
    Miller CW (1978) Survival and ambulation following hip fracture. J Bone Joint Surg Am 60:930–934PubMedGoogle Scholar
  8. 8.
    Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ III (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001–1005PubMedGoogle Scholar
  9. 9.
    Kreutzfeldt J, Haim M, Bach E (1984) Hip fracture among the elderly in a mixed urban and rural population. Age Ageing 13:111–119PubMedCrossRefGoogle Scholar
  10. 10.
    Dahl E (1980) Mortality and life expectancy after hip fractures. Acta Orthop Scand 51:163–170PubMedGoogle Scholar
  11. 11.
    Holmberg S, Conradi P, Kalen R, Thorngren KG (1986) Mortality after cervical hip fracture. 3002 patients followed for 6 years. Acta Orthop Scand 57:8–11PubMedGoogle Scholar
  12. 12.
    Parker MJ, Anand JK (1991) What is the true mortality of hip fractures? Public Health 105:443–446PubMedCrossRefGoogle Scholar
  13. 13.
    Poor G, Atkinson EJ, O’Fallon WM, Melton LJ III (1995) Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res 260–265Google Scholar
  14. 14.
    Schroder HM, Erlandsen M (1993) Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5–18.5 years. J Orthop Trauma 7:525–531PubMedCrossRefGoogle Scholar
  15. 15.
    Jensen JS, Tondevold E (1979) Mortality after hip fractures. Acta Orthop Scand 50:161–167PubMedCrossRefGoogle Scholar
  16. 16.
    Handoll HHG, Farrar MJ, McBirnie J et al (2002) Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database of Systematic Reviews CD000305Google Scholar
  17. 17.
    Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374PubMedCrossRefGoogle Scholar
  18. 18.
    Wehren LE, Hawkes WG, Orwig DL et al (2003) Gender differences in mortality after hip fracture: the role of infection. J Bone Mineral Res 18:2231–2237CrossRefGoogle Scholar
  19. 19.
    Ramnemark A, Nyberg L, Borssén B, Olsson T, Gustafson Y (1998) Fractures after stroke. Osteoporosis Int 8:92–95CrossRefGoogle Scholar
  20. 20.
    Ensrud KE, Thompson DE, Cauley JA et al (2000) Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48:241–249PubMedGoogle Scholar
  21. 21.
    Kado DM, Duong T, Stone KL et al (2003) Incident vertebral fractures and mortality in older women: a prospective study. Osteoporosis Int 14:589–594CrossRefGoogle Scholar
  22. 22.
    Browner WS, Pressman AR, Nevitt MC, Cummings SR (1996) Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med 156:1521–1525PubMedCrossRefGoogle Scholar
  23. 23.
    Ceder L, Elmqvist D, Svensson SE (1981) Cardiovascular and neurological function in elderly patients sustaining a fracture of the neck of the femur. J Bone Joint Surg Br 63B:560–566PubMedGoogle Scholar
  24. 24.
    Nettleman MD, Alsip J, Schrader M, Schulte M (1996) Predictors of mortality after acute hip fracture. J Gen Intern Med 11:765–767PubMedCrossRefGoogle Scholar
  25. 25.
    Bannister GC, Gibson AG, Ackroyd CE, Newman JH (1990) The fixation and prognosis of trochanteric fractures. A randomized prospective controlled trial. Clin Orthop Relat Res 242–246Google Scholar
  26. 26.
    Lavernia CJ (1998) Hemiarthroplasty in hip fracture care: effects of surgical volume on short-term outcome. J Arthroplasty 13:774–778PubMedCrossRefGoogle Scholar
  27. 27.
    Davis FM, Woolner DF, Frampton C et al (1987) Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth 59:1080–1088PubMedCrossRefGoogle Scholar
  28. 28.
    Bottle A, Aylin P (2006) Mortality associated with delay in operation after hip fracture: observational study. BMJ 332:947–951PubMedCrossRefGoogle Scholar
  29. 29.
    Bergeron E, Lavoie A, Moore L et al (2006) Is the delay to surgery for isolated hip fracture predictive of outcome in efficient systems? J Trauma 60:753–757PubMedGoogle Scholar
  30. 30.
    Halm EA, Wang JJ, Boockvar K et al (2003) Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture. Transfusion 43:1358–1365PubMedCrossRefGoogle Scholar
  31. 31.
    Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398–2399PubMedCrossRefGoogle Scholar
  32. 32.
    Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH (1999) The Danish National Hospital Register. Dan Med Bull 46:263–268PubMedGoogle Scholar
  33. 33.
    Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1–10PubMedCrossRefGoogle Scholar
  34. 34.
    Wacholder S, McLaughlin JK, Silverman DT, Mandel JS (1992) Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135:1019–1028PubMedGoogle Scholar
  35. 35.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383PubMedCrossRefGoogle Scholar
  36. 36.
    Vestergaard P, Rejnmark L, Mosekilde L (2006) Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark. Scand J Public Health 34:371–377PubMedCrossRefGoogle Scholar
  37. 37.
    Miettinen OS (1985) Theoretical epidemiology: principles of occurrence research in medicine, 1 edn. Wiley, New YorkGoogle Scholar
  38. 38.
    Boereboom FT, Raymakers JA, Duursma SA (1992) Mortality and causes of death after hip fractures in The Netherlands. Neth J Med 41:4–10PubMedGoogle Scholar
  39. 39.
    Cree MW, Juby AG, Carriere KC (2003) Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int 14:722–727PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2007

Authors and Affiliations

  1. 1.Department of Endocrinology and Metabolism C, Aarhus AmtssygehusAarhus University HospitalAarhusDenmark
  2. 2.The Osteoporosis ClinicAarhus AmtssygehusAarhus CDenmark

Personalised recommendations